Klin Farmakol Farm. 2012;26(3):113-116

Attitudes and adherence to pharmacologic therapy in patients with type 2 diabetes - a pilot project

Petra Matoulková¹, Jana Pavlatová¹, Iva Selke Krulichová²

¹ Farmaceutická fakulta, Katedra sociální a klinické farmacie, Univerzita Karlova v Praze

² Lékařská fakulta v Hradci Králové, Ústav lékařské biofyziky, Univerzita Karlova v Praze

Aim of the study: The aim of the study was to identify patient´s personal medication beliefs in the cohort of patients with type 2 diabetes

treated with hypoglycemic agents (ATC group: A10B) and to estimate prevalence of self-reported non-adherence.

Methods: A cross sectional study was conducted between October and December 2011 in two pharmacies. Czech translation of two

questionnaires „Beliefs about Medicines Questionnaire – Specific scale“ and „Medication Adherence Report Scale“ together with sociodemographic

characteristics and presence of comorbities were collected for each participant. All variables were self-reported.

Results: 73 patients were approached and 41 agreed to participate. 32,71 percent reported antihyperglycemic underuse while 9,76

percent was classified to be fully non-adherent. The mean score of the „BMQ-CZ; Necessity“ item was 3.89 (SD 0.87) and 2.6 (SD 0.82)

for the one item of the „BMQ-CZ; Concerns“. We did not identify cost-related underuse.

Conclusion: In our survey diabetes 2 patients with percieved concerns for antihyperglycemic use were identified using BMQ-CZ Specific

scale. Those patients may be in a risk of treatment non-adherence.

Keywords: diabetes mellitus, type 2, hypoglycemic agents, medication adherence, beliefs about medicines

Published: November 1, 2012  Show citation